These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15982353)

  • 41. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
    De Tommasi E; Iacoviello M; Romito R; Ceconi C; Guida P; Massari F; Francolini G; Bertocchi F; Ferrari R; Rizzon P; Pitzalis MV
    Am Heart J; 2003 Nov; 146(5):E17. PubMed ID: 14597946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term angiotensin-converting enzyme and angiotensin I--receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels.
    Multani MM; Krombach RS; Hendrick JW; Baicu SC; Joffs C; Sample JA; deGasparo M; Spinale FG
    J Card Fail; 2001 Dec; 7(4):348-54. PubMed ID: 11782859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
    Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J
    Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.
    Macdonald JE; Kennedy N; Struthers AD
    Heart; 2004 Jul; 90(7):765-70. PubMed ID: 15201246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of lisinopril on serum catecholamine concentrations both at rest and on exercise in patients with congestive cardiac failure. A double blind, placebo controlled, parallel group study.
    Fahy G; Deb B; Robinson K; Graham I
    Ir Med J; 1993; 86(4):134-5. PubMed ID: 8395488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease].
    Sazhina EIu; Kozlova IV; Rebrov AP; Al'tshuler MIu
    Klin Med (Mosk); 2006; 84(12):20-4. PubMed ID: 17294877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism.
    Koji T; Onishi K; Dohi K; Okamoto R; Tanabe M; Kitamura T; Ito M; Isaka N; Nobori T; Nakano T
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):632-9. PubMed ID: 12658066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
    Valdemarsson S; Edvinsson L; Ekman R; Hedner P; Sjöholm A
    J Intern Med; 1991 Oct; 230(4):325-31. PubMed ID: 1717629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
    Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C
    Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE
    Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):301-3. PubMed ID: 11714011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade.
    Giannattasio C; Achilli F; Failla M; Capra A; Vincenzi A; Valagussa F; Mancia G
    J Am Coll Cardiol; 2002 Apr; 39(8):1275-82. PubMed ID: 11955844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
    Davie AP; McMurray JJ
    Br J Clin Pharmacol; 2002 Jan; 53(1):37-42. PubMed ID: 11849193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
    van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
    J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.
    Hamroff G; Katz SD; Mancini D; Blaufarb I; Bijou R; Patel R; Jondeau G; Olivari MT; Thomas S; Le Jemtel TH
    Circulation; 1999 Mar; 99(8):990-2. PubMed ID: 10051289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.